Agios Pharmaceuticals (AGIO) Q3 2023 Earnings Call Transcript

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM ET

Company Participants

Brian Goff – Chief Executive Officer

Cecilia Jones – Chief Financial Officer

Tsveta Milanova – Chief Commercial Officer

Sarah Gheuens – Chief Medical Officer

Chris Taylor – Vice President, Investor Relations and Corporate Communications

Conference Call Participants

Divya Rao – TD Cowen

Lydia – Goldman Sachs

Tess Romero – JP Morgan

Unknown Analyst – RBC Capital Markets

Greg Harrison – Bank of America

Alex – Raymond James


Good day and thank you for standing by. Welcome to the Agios Pharmaceuticals Incorporated quarter three 2023 earnings conference call.

At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question during this session, you will need to press star-one-one on your telephone. You will then hear an automated message advising that your hand is raised. Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to Mr. Chris Taylor, VP Investor Relations and Corporate Communications. Please go ahead.

Chris Taylor

Thank you Operator. Good morning everyone and welcome to Agios’ third quarter 2023 conference call. You can access slides for today’s call by going to the Investors section of our website,

On today’s call, I am joined by our Chief Executive Officer, Brian Goff; Dr. Sarah Gheuens, Chief Medical Officer of Head of Research and Development; Tsveta Milanova, our Chief Commercial Officer; and Cecilia Jones, Chief Financial Officer.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from these expressed or implied by any forward-looking statements as a result of

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *